Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1077 studies found for:    Open Studies | "Colonic Diseases"
Show Display Options
Rank Status Study
21 Recruiting Evaluation of a Novel Electronic Transanal Irrigation System - Navina™ Smart
Condition: Neurogenic Bowel
Intervention: Device: Navina Smart
22 Recruiting The Expression of the Ionotropic Glutamate Receptors in Colon of IBS
Condition: Irritable Bowel Syndrome
Intervention: Procedure: colonoscopy
23 Recruiting Safety and Therapeutic Efficacy of Phosphate Enema (Kleen Enema) in Patients Undergoing Sigmoidoscopy
Condition: Irritable Bowel Syndrome
Intervention: Drug: Phosphate Enema (Kleen® Enema)
24 Recruiting Confocal Laser Endomicroscopy, IBS and Stress
Condition: Irritable Bowel Syndrome
Interventions: Drug: Stress;   Drug: Control
25 Recruiting Measuring Nerve Activity in Small Human Intestinal Biopsies in IBS (Irritable Bowel Syndrome)
Conditions: IBS;   Healthy
Intervention: Procedure: Rectal biopsies from IBS patients or healthy subjects will be taken during proctoscopy
26 Recruiting Peripheral Histamine 1 Receptor Blockade in IBS: Multicenter Trial
Condition: Irritable Bowel Syndrome (IBS)
Interventions: Drug: Ebastine;   Drug: Placebo
27 Recruiting Mesalazine Treatment in IBS (The MIBS Study)
Condition: Irritable Bowel Syndrome
Interventions: Drug: Mesalazine;   Drug: Placebo
28 Not yet recruiting Fructose Breath-testing in Irritable Bowel Syndrome (IBS)
Conditions: Functional Gastrointestinal Disorders;   Irritable Bowel Syndrome
Interventions: Procedure: Open breath test with fructose;   Procedure: Breath test with sweet placebo (Assugrin);   Procedure: Breath test with neutral placebo (still water);   Procedure: Blinded breath test with fructose
29 Recruiting A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: Napabucasin;   Drug: Fluorouracil;   Drug: Leucovorin;   Drug: Irinotecan;   Drug: Bevacizumab
30 Recruiting A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
Condition: Ulcerative Colitis
Interventions: Drug: LT-02;   Drug: LT-02 Placebo
31 Not yet recruiting Phase 2 Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Interventions: Drug: CY;   Biological: GVAX;   Drug: Pembrolizumab
32 Recruiting SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)
Condition: Metastatic Colorectal Cancer
Interventions: Drug: CY;   Biological: GVAX;   Drug: SGI-110
33 Recruiting Gut Permeability, Sensitivity and Symptomatology
Conditions: Irritable Bowel Syndrome;   Visceral Hypersensitivity
Interventions: Procedure: Gastrointestinal Permeability Test;   Procedure: Upper Endoscopy;   Procedure: Rectal Barostat and Infusion of Fats
34 Recruiting Biomarkers for Intestinal Permeability in Patients With Constipation
Conditions: Intestinal Diseases;   Irritable Bowel Syndrome;   Constipation
Interventions: Other: saccharides;   Procedure: esophagogastroduodenoscopy;   Procedure: flexible sigmoidoscopy
35 Recruiting Localized Therapeutics for the Treatment of Gastrointestinal Disorders II
Condition: Colitis, Ulcerative
Intervention: Drug: Thermosensitive gel rectal formulation
36 Not yet recruiting Prevention of Readmissions at IBD Centres of Excellence
Conditions: Colitis, Ulcerative;   Crohn Disease;   Inflammatory Bowel Diseases
Interventions: Behavioral: Nurse Follow-Up;   Other: Electronic Monitoring;   Other: Post-Discharge Questionnaire;   Other: Standard of Care
37 Not yet recruiting Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases
Conditions: Crohn's Disease;   Ulcerative Colitis;   Inflammatory Bowel Disease
Intervention: Drug: Vedolizumab
38 Recruiting Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
Conditions: Colitis, Ulcerative;   Bowel Diseases, Inflammatory
Intervention: Drug: Infliximab
39 Not yet recruiting Pilot Study of Fecal Transplantation Using a Unique Diet for Donor and Recipient in Moderate to Severe Treatment Refractory Colitis in Inflammatory Bowel Disease
Condition: Ulcerative Colitis
Interventions: Other: Fecal transplantation;   Other: Unique novel Diet for UC and Unique novel Diet for the donor + FMT;   Other: Unique novel Diet for UC
40 Recruiting Determination of the Aetiologies of Acute Colitis and Early Identification of Patients Requiring Diagnostic Colonoscopy
Condition: Colitis
Intervention: Other: Diagnostic

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.